JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



FIGURE 5. Outcome vs. curve type and early FMISO uptake: All patients with type 1 were responders. Patients with type 2 or 3 could further be discriminated by analyzing SUV 0–2 min after injection (A) and 5–14 min after injection (B). Area enclosed by rectangle represents area of high risk: All patients with data within this range experienced relapse.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE